MetLife Investment Management’s Cartesian Therapeutics RNAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-6,667
| Closed | -$87.9K | – | 2909 |
|
|
2025
Q1 | $87.9K | Hold |
6,667
| – | – | ﹤0.01% | 2583 |
|
|
2024
Q4 | $119K | Buy |
+6,667
| New | +$119K | ﹤0.01% | 2536 |
|
|
2024
Q3 | – | Sell |
-2,838
| Closed | -$76.7K | – | 2901 |
|
|
2024
Q2 | $76.7K | Buy |
+2,838
| New | +$76.7K | ﹤0.01% | 2692 |
|
|
2023
Q4 | – | Sell |
-2,073
| Closed | -$65.9K | – | 2857 |
|
|
2023
Q3 | $65.9K | Hold |
2,073
| – | – | ﹤0.01% | 2782 |
|
|
2023
Q2 | $69.6K | Buy |
+2,073
| New | +$69.6K | ﹤0.01% | 2848 |
|
|
2022
Q1 | – | Sell |
-1,203
| Closed | -$118K | – | 2765 |
|
|
2021
Q4 | $118K | Buy |
1,203
+654
| +119% | +$63.9K | ﹤0.01% | 2349 |
|
|
2021
Q3 | $68.5K | Sell |
549
-656
| -54% | -$81.9K | ﹤0.01% | 2515 |
|
|
2021
Q2 | $151K | Buy |
+1,205
| New | +$151K | ﹤0.01% | 2320 |
|
|
2020
Q3 | – | Sell |
-1,190
| Closed | -$101K | – | 2331 |
|
|
2020
Q2 | $101K | Buy |
+1,190
| New | +$101K | ﹤0.01% | 2250 |
|
|
2018
Q4 | – | Sell |
-309
| Closed | -$144K | – | 2588 |
|
|
2018
Q3 | $144K | Buy |
+309
| New | +$144K | ﹤0.01% | 2264 |
|